ARTICLE: mRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant
AUTHORS: Bezawit A Woldemeskel, Caroline C Garliss, Joel N Blankson
JOURNAL: Clin Infect Dis. 2022 Aug 24;75(1):e898-e901. doi: 10.1093/cid/ciab915.
Little is known about the decay kinetics of coronavirus disease 2019 vaccine-elicited severe acute respiratory syndrome coronavirus 2-specific T cells. In this study we show a modest decline in the frequency of these T cells at 6 months and demonstrate robust expansion in response to antigen and recognition of spike peptides from the Delta variant.
For the full article, click here.
For a link to the abstract, click here.